Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Association Between Interleukin-7 Receptor Gene Polymorphism and the Risk of Ulcerative Colitis as Well as the Response to Vedolizumab

NCT07398586 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Wenzhou Medical University as lead sponsor.

NCT NCT07398586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07398586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Association Between Interleukin-7 Receptor Gene Polymorphism and the Risk of Ulcerative Colitis as Well as the Response to Vedolizumab
Lead sponsor
Second Affiliated Hospital of Wenzhou Medical University
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2020
Completion date
December 31, 2024
Enrollment
898 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis (uc)